Standard Chemical & Pharmaceutical Co's quarterly Total Liabilities
declined
from Jun. 2025 (NT$2,933.93 Mil) to Sep. 2025 (NT$2,602.01 Mil) and
declined
from Sep. 2025 (NT$2,602.01 Mil) to Dec. 2025 (NT$2,509.09 Mil).
Standard Chemical & Pharmaceutical Co's annual Total Liabilities
declined
from Dec. 2023 (NT$3,051.39 Mil) to Dec. 2024 (NT$2,199.48 Mil) but then
increased
from Dec. 2024 (NT$2,199.48 Mil) to Dec. 2025 (NT$2,509.09 Mil).
Standard Chemical & Pharmaceutical Co Total Liabilities Related Terms
Standard Chemical & Pharmaceutical Co Total Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co Total Liabilities Chart
Standard Chemical & Pharmaceutical Co Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of NT$2,509 Mil mean?
Standard Chemical & Pharmaceutical Co (TPE:1720) has a Total Liabilities of NT$2,509 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Standard Chemical & Pharmaceutical Co and its competitors.
Is Standard Chemical & Pharmaceutical Co's Total Liabilities too high?
Standard Chemical & Pharmaceutical Co's current Total Liabilities is NT$2,509 Mil. Overall, Standard Chemical & Pharmaceutical Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Standard Chemical & Pharmaceutical Co's Total Liabilities compare to ZTS and UTHR?
Standard Chemical & Pharmaceutical Co's Total Liabilities of NT$2,509 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Standard Chemical & Pharmaceutical Co and its competitors. Standard Chemical & Pharmaceutical Co's current Total Liabilities is NT$2,509 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Chemical & Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co (TPE:1720) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$70.94, compared to a current price of NT$63.90 — trading 9.9% below its estimated fair value. The current Total Liabilities is NT$2,509 Mil. Standard Chemical & Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Standard Chemical & Pharmaceutical Co (TPE:1720), the current Total Liabilities is NT$2,509 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Standard Chemical & Pharmaceutical Co (TPE:1720) Overvalued in 2026?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$63.90 is trading 9.9% below its estimated GF Value™ of NT$70.94.
GuruFocus considers Standard Chemical & Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TPE:1720:
Total Liabilities: NT$2,509 Mil
GF Value™: NT$70.94 vs. price of NT$63.90 (9.9% below fair value)
No single metric tells the full story. See the TPE:1720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Standard Chemical & Pharmaceutical Co Business Description
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
95GF Score
Get the complete analysis for TPE:1720
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1720 has been successfully added to your 
